메뉴 건너뛰기




Volumn 9, Issue 2, 2009, Pages 327-336

Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: The 'ReSpECT' study

Author keywords

Delayed tacrolimus; Immunosuppression; Liver transplantation; Renal failure

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CORTICOSTEROID; DACLIZUMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; TACROLIMUS;

EID: 58849165272     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02493.x     Document Type: Article
Times cited : (241)

References (37)
  • 1
    • 85083136199 scopus 로고    scopus 로고
    • European Liver Transplant Registry. [cited 2008 May 20]; Available from
    • European Liver Transplant Registry. 2007 [cited 2008 May 20]; Available from : http://www.eltr.org/publi/index-rv.php3.
    • (2007)
  • 2
    • 58849143601 scopus 로고    scopus 로고
    • U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. [cited 2008 May 1]; Available from
    • U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients. 2007 OPTN/SRTR Annual Report: Transplant data 1997-2006. 2007 [cited 2008 May 1]; Available from : http://www.ustransplant. org/annual-reports/current/906d-li.html.
    • (2007) 2007 OPTN/SRTR Annual Report: Transplant Data 1997-2006
  • 3
    • 0042360213 scopus 로고    scopus 로고
    • Chronic renal failure after transplantation of a nonrenal organ
    • Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003 349 : 931 940.
    • (2003) N Engl J Med , vol.349 , pp. 931-940
    • Ojo, A.O.1    Held, P.J.2    Port, F.K.3
  • 4
    • 0036794560 scopus 로고    scopus 로고
    • Chronic renal dysfunction late after liver transplantation
    • Cohen AJ, Stegall MD, Rosen CB et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl 2002 8 : 916 921.
    • (2002) Liver Transpl , vol.8 , pp. 916-921
    • Cohen, A.J.1    Stegall, M.D.2    Rosen, C.B.3
  • 5
    • 30444447516 scopus 로고    scopus 로고
    • Kidney dysfunction in the recipients of liver transplants
    • Wilkinson A, Pham PT. Kidney dysfunction in the recipients of liver transplants. Liver Transpl 2005 11 (11 Suppl 2 S47 S51.
    • (2005) Liver Transpl , vol.11 , Issue.112
    • Wilkinson, A.1    Pham, P.T.2
  • 7
    • 33644802143 scopus 로고    scopus 로고
    • Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels
    • Morard I, Mentha G, Spahr L et al. Long-term renal function after liver transplantation is related to calcineurin inhibitors blood levels. Clin Transplant 2006 20 : 96 101.
    • (2006) Clin Transplant , vol.20 , pp. 96-101
    • Morard, I.1    Mentha, G.2    Spahr, L.3
  • 8
    • 10744228665 scopus 로고    scopus 로고
    • Early kidney dysfunction post liver transplantation predicts late chronic kidney disease
    • Velidedeoglu E, Bloom RD, Crawford MD et al. Early kidney dysfunction post liver transplantation predicts late chronic kidney disease. Transplantation 2004 77 : 553 556.
    • (2004) Transplantation , vol.77 , pp. 553-556
    • Velidedeoglu, E.1    Bloom, R.D.2    Crawford, M.D.3
  • 9
    • 0035668548 scopus 로고    scopus 로고
    • End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment
    • Gonwa TA, Mai ML, Melton LB et al. End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: Risk of development and treatment. Transplantation 2001 72 : 1934 1939.
    • (2001) Transplantation , vol.72 , pp. 1934-1939
    • Gonwa, T.A.1    Mai, M.L.2    Melton, L.B.3
  • 10
    • 0038824912 scopus 로고    scopus 로고
    • Independent risk factors and natural history of renal dysfunction in liver transplant recipients
    • Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 2003 9 : 741 747.
    • (2003) Liver Transpl , vol.9 , pp. 741-747
    • Pawarode, A.1    Fine, D.M.2    Thuluvath, P.J.3
  • 11
    • 10344236478 scopus 로고    scopus 로고
    • Nonnephrotoxic immunosuppression in patients after liver transplantation
    • Kniepeiss D, Iberer F, Schaffellner S et al. Nonnephrotoxic immunosuppression in patients after liver transplantation. Int Immunopharmacol 2005 5 : 133 136.
    • (2005) Int Immunopharmacol , vol.5 , pp. 133-136
    • Kniepeiss, D.1    Iberer, F.2    Schaffellner, S.3
  • 12
    • 10344250408 scopus 로고    scopus 로고
    • Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction
    • Kornberg A, Küpper B, Hommann M, Scheele J. Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction. Int Immunopharmacol 2005 5 : 141 146.
    • (2005) Int Immunopharmacol , vol.5 , pp. 141-146
    • Kornberg, A.1    Küpper, B.2    Hommann, M.3    Scheele, J.4
  • 13
    • 33845516689 scopus 로고    scopus 로고
    • Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation
    • Pageaux GP, Rostaing L, Calmus Y et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 2006 12 : 1755 1760.
    • (2006) Liver Transpl , vol.12 , pp. 1755-1760
    • Pageaux, G.P.1    Rostaing, L.2    Calmus, Y.3
  • 14
    • 22144490224 scopus 로고    scopus 로고
    • Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results
    • Reich DJ, Clavien PA, Hodge EE. Mycophenolate mofetil for renal dysfunction in liver transplant recipients on cyclosporine or tacrolimus: Randomized, prospective, multicenter pilot study results. Transplantation 2005 80 : 8 25.
    • (2005) Transplantation , vol.80 , pp. 8-25
    • Reich, D.J.1    Clavien, P.A.2    Hodge, E.E.3
  • 15
    • 0142155129 scopus 로고    scopus 로고
    • Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus
    • Fairbanks KD, Eustace JA, Fine D, Thuluvath PJ. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus. Liver Transpl 2003 9 : 1079 1085.
    • (2003) Liver Transpl , vol.9 , pp. 1079-1085
    • Fairbanks, K.D.1    Eustace, J.A.2    Fine, D.3    Thuluvath, P.J.4
  • 16
    • 0035941732 scopus 로고    scopus 로고
    • Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: A randomised controlled study
    • Schlitt HJ, Barkmann A, Böker KH et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: A randomised controlled study. Lancet 2001 357 : 587 591.
    • (2001) Lancet , vol.357 , pp. 587-591
    • Schlitt, H.J.1    Barkmann, A.2    Böker, K.H.3
  • 18
    • 0035993617 scopus 로고    scopus 로고
    • Liver transplant induction trial of daclizumab to spare calcineurin inhibition
    • Heffron TG, Smallwood GA, Pillen T et al. Liver transplant induction trial of daclizumab to spare calcineurin inhibition. Transplant Proc 2002 34 : 1514 1515.
    • (2002) Transplant Proc , vol.34 , pp. 1514-1515
    • Heffron, T.G.1    Smallwood, G.A.2    Pillen, T.3
  • 19
    • 25144502966 scopus 로고    scopus 로고
    • Evaluation of renal function in liver transplant recipients receiving daclizumab Zenapax, mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial
    • Yoshida EM, Marotta PJ, Greig PD et al. Evaluation of renal function in liver transplant recipients receiving daclizumab Zenapax, mycophenolate mofetil, and a delayed, low-dose tacrolimus regimen vs a standard-dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial. Liver Transpl 2005 11 : 1064 1072.
    • (2005) Liver Transpl , vol.11 , pp. 1064-1072
    • Yoshida, E.M.1    Marotta, P.J.2    Greig, P.D.3
  • 20
    • 33644616547 scopus 로고    scopus 로고
    • Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.[see comment]
    • Brunet M, Cirera I, Martorell J et al. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.[see comment]. Transplantation 2006 81 : 541 546.
    • (2006) Transplantation , vol.81 , pp. 541-546
    • Brunet, M.1    Cirera, I.2    Martorell, J.3
  • 21
    • 34250613511 scopus 로고    scopus 로고
    • Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil
    • Jain A, Venkataramanan R, Kwong T et al. Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil. Liver Transpl 2007 13 : 791 796.
    • (2007) Liver Transpl , vol.13 , pp. 791-796
    • Jain, A.1    Venkataramanan, R.2    Kwong, T.3
  • 22
    • 0016916438 scopus 로고
    • Prediction of creatinine clearance from serum creatinine
    • Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976 16 : 31 41.
    • (1976) Nephron , vol.16 , pp. 31-41
    • Cockcroft, D.W.1    Gault, M.H.2
  • 23
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
    • (1999) Ann Intern Med , vol.130 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 25
    • 21644483598 scopus 로고    scopus 로고
    • One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient
    • Montini G, Murer L, Ghio L et al. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Transpl Int 2005 18 : 36 42.
    • (2005) Transpl Int , vol.18 , pp. 36-42
    • Montini, G.1    Murer, L.2    Ghio, L.3
  • 26
    • 0034658102 scopus 로고    scopus 로고
    • The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients
    • Eckhoff DE, McGuire B, Sellers M et al. The safety and efficacy of a two-dose daclizumab (zenapax) induction therapy in liver transplant recipients. Transplantation 2000 69 : 1867 1872.
    • (2000) Transplantation , vol.69 , pp. 1867-1872
    • Eckhoff, D.E.1    McGuire, B.2    Sellers, M.3
  • 27
    • 0035999038 scopus 로고    scopus 로고
    • Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: A pilot efficacy and safety study
    • Fahlke J, Wolff S, Mantke R et al. Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: A pilot efficacy and safety study. Transplant Proc 2002 34 : 1242 1244.
    • (2002) Transplant Proc , vol.34 , pp. 1242-1244
    • Fahlke, J.1    Wolff, S.2    Mantke, R.3
  • 28
    • 0345382811 scopus 로고    scopus 로고
    • Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation
    • Vincenti F, Pace D, Birnbaum J et al. Pharmacokinetic and pharmacodynamic studies of one or two doses of daclizumab in renal transplantation. Am J Transplant 2003 3 : 50 52.
    • (2003) Am J Transplant , vol.3 , pp. 50-52
    • Vincenti, F.1    Pace, D.2    Birnbaum, J.3
  • 29
    • 0032570304 scopus 로고    scopus 로고
    • Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation
    • Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. Transplantation 1998 65 : 180 187.
    • (1998) Transplantation , vol.65 , pp. 180-187
    • Eckhoff, D.E.1    McGuire, B.M.2    Frenette, L.R.3    Contreras, J.L.4    Hudson, S.L.5    Bynon, J.S.6
  • 30
    • 0032573724 scopus 로고    scopus 로고
    • A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation
    • Fisher RA, Ham JM, Marcos A et al. A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. Transplantation 1998 66 : 1616 1621.
    • (1998) Transplantation , vol.66 , pp. 1616-1621
    • Fisher, R.A.1    Ham, J.M.2    Marcos, A.3
  • 31
    • 0032573415 scopus 로고    scopus 로고
    • A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: An interim report
    • Jain AB, Hamad I, Rakela J et al. A prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil in primary adult liver transplant recipients: An interim report. Transplantation 1998 66 : 1395 1398.
    • (1998) Transplantation , vol.66 , pp. 1395-1398
    • Jain, A.B.1    Hamad, I.2    Rakela, J.3
  • 32
    • 33644820721 scopus 로고    scopus 로고
    • Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation
    • Lake JR, David KM, Steffen BJ, Chu AH, Gordon RD, Wiesner RH. Addition of MMF to dual immunosuppression does not increase the risk of malignant short-term death after liver transplantation. Am J Transplant 2005 5 : 2961 2967.
    • (2005) Am J Transplant , vol.5 , pp. 2961-2967
    • Lake, J.R.1    David, K.M.2    Steffen, B.J.3    Chu, A.H.4    Gordon, R.D.5    Wiesner, R.H.6
  • 33
    • 22144442065 scopus 로고    scopus 로고
    • Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C
    • Wiesner RH, Shorr JS, Steffen BJ, Chu AH, Gordon RD, Lake JR. Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl 2005 11 : 750 759.
    • (2005) Liver Transpl , vol.11 , pp. 750-759
    • Wiesner, R.H.1    Shorr, J.S.2    Steffen, B.J.3    Chu, A.H.4    Gordon, R.D.5    Lake, J.R.6
  • 35
    • 0038237028 scopus 로고    scopus 로고
    • Tacrolimus: A further update of its use in the management of organ transplantation
    • Scott LJ, McKeage K, Keam SJ, Plosker GL. Tacrolimus: A further update of its use in the management of organ transplantation. Drugs 2003 63 : 1247 1297.
    • (2003) Drugs , vol.63 , pp. 1247-1297
    • Scott, L.J.1    McKeage, K.2    Keam, S.J.3    Plosker, G.L.4
  • 36
    • 10744227579 scopus 로고    scopus 로고
    • Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease
    • Paramesh AS, Roayaie S, Doan Y et al. Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease. Clin Transplant 2004 18 : 94 99.
    • (2004) Clin Transplant , vol.18 , pp. 94-99
    • Paramesh, A.S.1    Roayaie, S.2    Doan, Y.3
  • 37
    • 34249897219 scopus 로고    scopus 로고
    • Renal dysfunction in liver transplant patients: Comparing patients transplanted for liver tumor or acute or chronic disease
    • Aberg F, Koivusalo AM, Höckerstedt K, Isoniemi H. Renal dysfunction in liver transplant patients: Comparing patients transplanted for liver tumor or acute or chronic disease. Transpl Int 2007 20 : 591 599.
    • (2007) Transpl Int , vol.20 , pp. 591-599
    • Aberg, F.1    Koivusalo, A.M.2    Höckerstedt, K.3    Isoniemi, H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.